Yashoda Hospitals hosts Bronchus 2025 Conference in Hyderabad, uniting global experts to address lung cancer challenges.

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

The fourth edition of Bronchus 2025, an Interventional Pulmonology Conference, brought together medical experts from across ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

Cancer a life-threatening disease can spread or metastasise from its original location to other parts of the body The lungs are a frequent site of metastasis An oncologist explains why ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

BENGALURU: When 52-year-old Rahul (name altered), a non-smoker and fitness enthusiast, started experiencing a persistent cough, he initially thought it was a se ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for ...